Linda Sevilla
Internal Medicine · van Nuys, CANPI 1285785980
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 301 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,507 and has fallen 94.6% since, to $82 in 2023. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $17.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$640
- Lilly USA, LLC$533
- Mannkind Corporation$531
- Dexcom, Inc.$517
- Boehringer Ingelheim$397
- AstraZeneca$389
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,09199%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $640 |
| Lilly USA, LLC | 26 | $533 |
| Mannkind Corporation | 35 | $531 |
| Dexcom, Inc. | 32 | $517 |
| Boehringer Ingelheim | 20 | $397 |
| AstraZeneca | 22 | $389 |
| Abbott | 11 | $235 |
| Sanofi-aventis U.S. LLC | 14 | $235 |
| Merck | 13 | $217 |
| Insulet Corporation | 10 | $211 |
| Amgen(2 entities) | 8 | $175 |
| Corcept Therapeutics | 10 | $174 |
| Medtronic(2 entities) | 7 | $107 |
| Zealand Pharma US, Inc. | 5 | $88 |
| Tandem Diabetes Care, Inc. | 5 | $79 |
| AbbVie(2 entities) | 3 | $63 |
| Valeritas, Inc. | 3 | $59 |
| Senseonics, Incorporated | 2 | $41 |
| Lifescan, Inc. | 2 | $40 |
| Radius Health, Inc. | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| GSK | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 1 | $27 |
| BD | 1 | $26 |
| Boston Scientific | 1 | $24 |
| Johnson & Johnson | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Sun Pharmaceutical Industries Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Shire North American Group Inc | 1 | $20 |
| Antares Pharma, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Companion Medical, Inc. | 1 | $14 |
| Amryt Pharma Holdings Ltd | 1 | $13 |
| Apria Healthcare LLC | 1 | $11 |
How this compares
$5,117 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Other internal medicine in van Nuys
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.